Company / EPS (Basic)
Crinetics Pharmaceuticals, Inc. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$4.95
FY2025
5-year range
-$4.95 / -$2.80
FY2021-FY2025
Trend
-34.1%
vs FY2024
Sector context
#178 of 208
Health Care
What the data says
Crinetics Pharmaceuticals, Inc.'s eps (basic) of $-4.95 is lower than 86% of companies in the Health Care sector (FY2025). Declined from $-3.69 to $-4.95 over the past 2 years.
Based on SEC 10-K filings.
-4.95 in FY2025.
Declined from $-3.69 to $-4.95 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 208This company -$4.95 Sector average -$0.87
▼
-468.6% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 34.1% year-over-year.
- Ranks #178 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.95 | -34.1% |
| FY2024 | -$3.69 | +0.0% |
| FY2023 | -$3.69 | -17.1% |
| FY2022 | -$3.15 | -12.5% |
| FY2021 | -$2.80 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026